Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiologically based pharmacokinetics of bisphenol A.

Beom Soo Shin1, Chul Hwan Kim, Yoon Sik Jun

  • 1College of Pharmacy, Sungkyunkwan University, Kyonggi-do, Korea.

Journal of Toxicology and Environmental Health. Part A
|October 30, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical stress-driven conformational compaction of polydeoxyribonucleotide for enhanced transdermal regenerative therapy.

Biomaterials science·2026
Same author

Fibro-osseous pseudotumor of the digit: a challenging case involving the distal interphalangeal joint and flexor tendon.

Skeletal radiology·2026
Same author

RETRACTED: Lee et al. Protective Effects of <i>Oenothera biennis</i> Against Hydrogen Peroxide-Induced Oxidative Stress and Cell Death in Skin Keratinocytes. <i>Life</i> 2020, <i>10</i>, 255.

Life (Basel, Switzerland)·2026
Same author

Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

A multi-compartment pulsatile drug delivery system for sequential release: in vitro and in vivo evaluation.

Drug delivery and translational research·2026
Same author

Population pharmacokinetic model-based IVIVC incorporating active metabolite kinetics: Application to aceclofenac sustained-release formulations.

International journal of pharmaceutics·2026

A new physiologically based pharmacokinetic (PBPK) model accurately predicts bisphenol A (BPA) distribution in rats and humans. This BPA model aids in understanding tissue exposure risks from environmental contact.

Area of Science:

  • Pharmacokinetics and Toxicological Modeling
  • Environmental Health Sciences

Background:

  • Bisphenol A (BPA) is an endocrine-disrupting chemical with widespread human exposure.
  • Understanding BPA's tissue distribution and pharmacokinetic behavior is crucial for risk assessment.

Purpose of the Study:

  • To develop and validate a physiologically based pharmacokinetic (PBPK) model for BPA in rats and humans.
  • To predict BPA's blood and tissue concentrations following various administration routes and doses.

Main Methods:

  • A PBPK model incorporating major organs (vein, artery, lung, liver, spleen, kidneys, heart, testes, muscle, brain, adipose tissue, stomach, small intestine) was constructed.
  • Model validation involved comparing predictions with experimental data from rats after multiple intravenous (IV) injections.

Related Experiment Videos

  • The validated model was used to simulate BPA levels in a human subject after single IV and multiple oral administrations.

    • Main Results:

    • The PBPK model accurately predicted steady-state BPA levels in rat blood and tissues.
    • Simulated human blood BPA levels post-administration were consistent with reported basal levels.
    • Predicted human pharmacokinetic parameters (CL, Vss, t1/2) aligned with previous allometric scaling predictions.

    Conclusions:

    • The developed PBPK model provides a robust tool for predicting BPA pharmacokinetics and tissue distribution.
    • This model can enhance understanding of BPA's behavior in the body, informing human health risk assessments.
    • The PBPK model offers valuable insights into tissue distribution resulting from human BPA exposure.